In 2023, the antiinfective medicine sales in Japan stood at 97.60 billion Japanese Yens. According to the forecasted data, sales are anticipated to steadily decline from 2024 to 2028. Specifically, the year-on-year variation shows a consistent decrease: 8.74% in 2025, 10.61% in 2026, 11.73% in 2027, and 13.17% in 2028. The compound annual growth rate (CAGR) over the five years is approximately -10.21%.
Future trends to watch for:
- Increased focus on generic antiinfective medicines as a cost-saving measure.
- Government policies and incentives to promote the development of novel antiinfective treatments.
- Impact of new pathogens and potential pandemics on market demand.
- Technological advancements in drug development and diagnostics.
- Growing awareness and preventive measures potentially reducing the need for antiinfective treatments.